TODAY'S MARKET INTELLIGENCE
Apeloa Pharmaceutical 2026 H1 Net Profit RMB 522M, Down 7.22% YoY
English summary
Apeloa Pharmaceutical reported 2026 H1 revenue of RMB 4.823 billion, down 11.41% YoY, and net profit of RMB 522 million, down 7.22% YoY. The company plans a cash dividend of RMB 1.39 per 10 shares (tax included).
The English text is machine translated and may require verification against the Chinese version.
Browse today's intelligence